Massachusetts-based LexaGene markets a point-of-need clinical PCR system that transforms results in about two hours, known as MiQLab
(,) announced that it will be presented at three investor relations conferences in early October.
Company management will also participate in one-on-one meetings at each conference.
LexaGene, based in Beverly, Mass., Markets a point-of-need clinical PCR system that turns results in about two hours, known as MiQLab.
READ: LexaGene Successfully Demonstrates Its MiQLab Diagnostic Tool For The First Time At A Series Of Trade Shows
âAttending these conferences allows us to educate current investors and present LexaGene as an investment opportunity for future investors,â Dr. Jack Regan, CEO and Founder of LexaGene, said in a statement.
âThe veterinary shows we attended in September made it clear that our technology is at the forefront of innovation and is expected to change the way diagnostics are made in veterinary medicine. We are excited about the increasing adoption of our MiQLab system in more veterinary hospitals, where vets want to provide the best possible care by using the MiQLab for rapid clinical PCR testing for pathogens and antimicrobial resistance.
The three conferences include:
- BioFuture 2021, October 5-6: Top innovators, investors and business leaders will come together to participate in discussions that will shape and transform the future of healthcare by harnessing the power of the life sciences ecosystem and its impact on healthcare, LexaGene will provide an overview of its open access technology and the role it can play in key life science verticals.
- Lytham Partners Fall 2021 Investor Conference, October 5-7. The next generation of innovators will provide a diverse and effective platform to connect small-cap companies with targeted, high-quality institutional investors. An audio webcast of the presentation will be available on the LexaGene website.
- Virtual Small Cap Growth Investor Conference, October 7. It will be a live interactive event, where investors are invited to ask questions of companies in real time. This is the premier proprietary investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham